Header Logo

Connection

RASHMI KRISHNA MURTHY to Elafin

Back to Details
This is a "connection" page, showing publications RASHMI KRISHNA MURTHY has written about Elafin.
RASHMI KRISHNA MURTHY
Connection Strength
0.036
Elafin
  1. Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and Bevacizumab. JAMA Oncol. 2017 Apr 01; 3(4):509-515.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.